12 HR Ampyra 10 MG Extended Release Oral Tablet
- RxCUI
- 897025
- RxNorm name
- 12 HR Ampyra 10 MG Extended Release Oral Tablet
- Display name
- 12 HR Ampyra 10 MG Extended Release Oral Tablet
- Full name
- 12 HR Ampyra 10 MG Extended Release Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:59
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AMPYRA | DALFAMPRIDINE | Merz Pharmaceuticals, LLC | 550eb76a-e4a6-4fa1-ad65-c0fd8b0ce783 | 2026-01-16 | Warnings, Adverse reactions | 897025 |
| AMPYRA | DALFAMPRIDINE | Merz Pharmaceuticals, LLC | 974fb2af-7012-4989-b330-e44a31c9c3e5 | 2025-05-05 | Warnings, Adverse reactions | 897025 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 550eb76a-e4a6-4fa1-ad65-c0fd8b0ce783 | Ampyra 10 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR dalfampridine 10 MG Extended Release Oral Tablet [Ampyra] [SBD] · 12 HR Ampyra 10 MG Extended Release Oral Tablet [SY] · Ampyra 10 MG 12 HR Extended Release Oral Tablet [SY] | 4 | 22 | These highlights do not include all the information needed to use AMPYRA safely and effectively. See full prescribing information for AMPYRA. AMPYRA ® (dalfampridine) extended-release tablets, for oral use Initial U.S. Approval: 2010 | 20260116 |
| 974fb2af-7012-4989-b330-e44a31c9c3e5 | Ampyra 10 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR dalfampridine 10 MG Extended Release Oral Tablet [Ampyra] [SBD] · 12 HR Ampyra 10 MG Extended Release Oral Tablet [SY] · Ampyra 10 MG 12 HR Extended Release Oral Tablet [SY] | 4 | 1 | These highlights do not include all the information needed to use AMPYRA safely and effectively. See full prescribing information for AMPYRA. AMPYRA ® (dalfampridine) extended-release tablets, for oral use Initial U.S. Approval: 2010 | 20250505 |